EQNAX
Price
$21.62
Change
+$0.12 (+0.56%)
Updated
Jan 17 closing price
Net Assets
614.65M
VIVIX
Price
$68.15
Change
+$0.43 (+0.63%)
Updated
Jan 17 closing price
Net Assets
183.52B
Ad is loading...

EQNAX vs VIVIX

Header iconEQNAX vs VIVIX Comparison
Open Charts EQNAX vs VIVIXBanner chart's image
MFS Equity Income A
Price$21.62
Change+$0.12 (+0.56%)
VolumeN/A
Net Assets614.65M
Vanguard Value Index I
Price$68.15
Change+$0.43 (+0.63%)
VolumeN/A
Net Assets183.52B
EQNAX vs VIVIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
EQNAX vs. VIVIX commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EQNAX is a Buy and VIVIX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
VIVIX has more cash in the bank: 184B vs. EQNAX (615M). VIVIX pays higher dividends than EQNAX: VIVIX (2.37) vs EQNAX (1.56). EQNAX was incepted earlier than VIVIX: EQNAX (12 years) vs VIVIX (27 years). EQNAX is a more actively managed with annual turnover of: 42.00 vs. VIVIX (10.00). EQNAX has a lower initial minimum investment than VIVIX: EQNAX (1000) vs VIVIX (5000000). VIVIX annual gain was more profitable for investors over the last year : 18.21 vs. EQNAX (12.86). VIVIX return over 5 years is better than : 44.19 vs. EQNAX (36.19).
EQNAXVIVIXEQNAX / VIVIX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence12 years27 years-
Gain YTD3.2473.211101%
Front LoadN/AN/A-
Min. Initial Investment100050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets615M184B0%
Annual Yield % from dividends1.562.3766%
Returns for 1 year12.8618.2171%
Returns for 3 years12.0218.4665%
Returns for 5 years36.1944.1982%
Returns for 10 years88.88111.1380%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VMGIX104.720.72
+0.69%
Vanguard Mid-Cap Growth Index Investor
GAONX20.080.10
+0.50%
JPMorgan Global Allocation R2
TRZYX16.600.03
+0.18%
T. Rowe Price Latin America Z
PEMCX12.91N/A
N/A
Principal Edge MidCap A
HGHYX43.73-0.31
-0.70%
Hartford Healthcare Y